2023. The Higher Severity Index of Vasomotor Perimenopausal Symptoms Signals the Need to Evaluate Coexisting Metabolic Syndrome for CVD Risk Factors Stratification Experience. Medical Forum Monthly. 34, 5 (May 2023).